Skip to main navigation
Cue Logo
Skip to Content
Cue Logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Corporate Governance
    • Governance Overview
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact Investor Relations

SEC
Filings

Filing date Form Description Filing Group View
Jun 16, 2020 D
Other
0001628945-20-000003.pdf
0001628945-20-000003.rtf
0001628945-20-000003.xls
May 16, 2017 D
Other
0000897069-17-000307.pdf
0000897069-17-000307.rtf
0000897069-17-000307.xls
Dec 29, 2014 D
Other
0000897069-14-000499.pdf
0000897069-14-000499.rtf
0000897069-14-000499.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Current page 21
Displaying 201 - 203 of 203 results

Data provided by Kaleidoscope.

Shareholder Tools

Print Page Print Page
Email Alerts Email Alerts
RSS RSS
Contact Contact

This website contains depictions of contemplated future products and future care offerings that are still under development by Cue Health and that have not received regulatory authorization, clearance or approval. Currently, Cue Health's products authorized for commercial sale in the United States are the Cue COVID-19 Test Kit and the Cue Mpox Molecular Test Kit, both authorized under Emergency Use Authorization from the U.S. Food & Drug Administration (the “FDA”) and the COVID-19 Molecular Test Kit (De Novo granted by the FDA).

  • © 2023 Cue Health Inc. All rights reserved. Cue and the Cue logo are registered trademarks of Cue Health Inc.